Hospital centralized monitoring of clinical safety of Shenkang Injection after marketing

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100048425

Enrollment

Unknown

Registered

2021-07-06

Start date

2021-08-01

Completion date

Unknown

Last updated

2023-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

case series:Use Shenkang Injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: During the monitoring period, inpatients receiving Shenkang injection treatment in each monitoring hospital.

Exclusion criteria

Exclusion criteria: Inpatients who are unable to collect the information needed for this study.

Design outcomes

Primary

Measure	Time frame
Adverse Drug Reactions/Events;	—

Countries

China

Contacts

Public ContactLi Xuelin

The First Affiliated Hospital of He'nan University of Chinese Medicine

lixuelin450000@163.com+86 13703711133

Outcome results